Quincke's Edema (Angioedema) – A Complete Patient Guide

Overview

Quincke’s edema, more commonly called angioedema, is a sudden swelling of the deeper layers of the skin and mucous membranes. The swelling typically involves the eyelids, lips, tongue, throat, hands, feet, or genital area and can develop within minutes to hours.

Although anyone can experience angioedema, it is most frequently seen in:

• Adults aged 20‑50 years (the average age of onset for hereditary forms is 20 years) [1].
• Women slightly more often than men in the acquired (allergic) form [2].
• Individuals with a family history of hereditary angioedema (HAE) [3].

Prevalence estimates vary because many mild cases go unreported, but:

• Acquired (allergic) angioedema affects roughly 0.1 %–0.5 % of the general population [4].
• Hereditary angioedema occurs in about **1 in 50,000‑100,000** people worldwide [5].

Symptoms

Angioedema is characterized by non‑pitting, non‑itchy swelling that can be painful or uncomfortable. Common symptoms include:

General Features

• Localized swelling – sudden enlargement of skin or mucosa; the skin appears smooth, tight, and may look “flushed.”
• Rapid onset – usually develops within minutes to a few hours after exposure to a trigger.
• Pain or tenderness – especially when the swelling involves the tongue or throat.
• Absence of rash – unlike urticaria (hives), angioedema typically lacks raised wheals.

Typical Sites

• Lips and perioral area – swelling around the mouth is the most frequent presentation.
• Eyelids and face – may cause a “puffy” look.
• Hands, feet, and genitals – can interfere with mobility or sexual activity.
• Oral cavity, tongue, and throat – when these areas are involved, breathing can become dangerous.
• Gastrointestinal tract – in rare cases, swelling of the intestinal wall leads to abdominal pain, nausea, vomiting, or diarrhea (often misdiagnosed as an acute abdomen) [6].

Associated Symptoms

• Feeling of “tightness” in the throat (especially with laryngeal involvement).
• Difficulty speaking or swallowing.
• Shortness of breath or wheezing (if airway is compromised).
• Occasional itching or burning sensation (more common in allergic angioedema).

Causes and Risk Factors

1. Allergic (Acquired) Angioedema

• IgE‑mediated reactions to foods (e.g., nuts, shellfish), insect stings, medications (especially penicillins, NSAIDs), or latex.
• Drug‑induced – ACE inhibitors (e.g., lisinopril, enalapril) are the leading medication cause, responsible for up to 30 % of drug‑related angioedema [7].
• Infections – viral (e.g., hepatitis C), bacterial, or parasitic infections can trigger immune activation.

2. Hereditary Angioedema (HAE)

• Caused by a deficiency or dysfunction of C1‑esterase inhibitor (C1‑INH), a protein that regulates the complement and contact systems.
• Two main types:
  • HAE‑Type I (≈85 %): low C1‑INH levels.
  • HAE‑Type II (≈15 %): normal or high levels but dysfunctional protein.
• Autosomal dominant inheritance; a 50 % chance of passing the gene to offspring [5].

3. Acquired C1‑INH Deficiency

• Usually associated with lymphoproliferative disorders (e.g., non‑Hodgkin lymphoma) or auto‑immune diseases.
• Occurs later in life (typically >50 years).

Risk Factors

• Family history of hereditary angioedema.
• Current use of ACE inhibitors or DPP‑4 inhibitors.
• History of allergic disorders (asthma, allergic rhinitis, eczema).
• Women with hormonal fluctuations (menstruation, pregnancy, oral contraceptives) may experience more frequent attacks [8].
• Stress, trauma, or dental procedures can precipitate attacks in susceptible individuals.

Diagnosis

The diagnostic work‑up aims to identify the underlying mechanism (allergic vs. bradykinin‑mediated) because treatment differs.

1. Clinical Evaluation

• Detailed history: onset, duration, triggers, family history, medication use.
• Physical exam: location and extent of swelling; assess airway patency.

2. Laboratory Tests

• C4 complement level – low in most HAE patients; normal in allergic angioedema.
• C1‑INH antigenic level and functional activity – distinguishes Type I vs. Type II HAE.
• Complete blood count, liver function, and renal panel to rule out other causes.
• If drug‑induced, discontinue the suspected medication and monitor for resolution.

3. Specific Tests

• Allergy testing (skin prick or specific IgE) when a food or environmental trigger is suspected.
• Imaging (e.g., CT of neck) only if airway compromise is suspected and physical exam is inconclusive.
• Genetic testing for SERPING1 mutations can confirm hereditary angioedema, especially in ambiguous cases.

4. Differential Diagnosis

Conditions that can mimic angioedema include cellulitis, deep vein thrombosis, contact dermatitis, and hereditary gelatinous idiopathic edema. A careful exam and appropriate labs help differentiate.

Treatment Options

1. Acute Management

• Airway protection – immediate assessment; if any sign of airway compromise, call emergency services (see below).
• Allergic (histaminergic) angioedema:
  • Oral or intramuscular antihistamines (e.g., cetirizine 10 mg, diphenhydramine 25‑50 mg).
  • Short‑course corticosteroids (e.g., prednisone 40‑60 mg daily for 5‑7 days) for moderate‑severe attacks.
  • If anaphylaxis is present, administer intramuscular epinephrine** (0.3 mg of 1:1000) immediately.
• Bradykinin‑mediated angioedema** (HAE or ACE‑inhibitor related):
  • C1‑INH concentrate** (plasma‑derived or recombinant) 20 U/kg IV.
  • Icatibant** (a bradykinin B2 receptor antagonist) 30 mg subcutaneously, repeat every 6 hours if needed.
  • Ecallantide** (kallikrein inhibitor) 30 mg subcutaneously – approved for hereditary angioedema.
  These agents act rapidly (within 30‑90 minutes) and are the treatment of choice for HAE attacks [9].